ES2085898T3 - Tratamiento de la enfermedad hepatobiliar con compuestos 15-cetoprostaglandina. - Google Patents

Tratamiento de la enfermedad hepatobiliar con compuestos 15-cetoprostaglandina.

Info

Publication number
ES2085898T3
ES2085898T3 ES90311457T ES90311457T ES2085898T3 ES 2085898 T3 ES2085898 T3 ES 2085898T3 ES 90311457 T ES90311457 T ES 90311457T ES 90311457 T ES90311457 T ES 90311457T ES 2085898 T3 ES2085898 T3 ES 2085898T3
Authority
ES
Spain
Prior art keywords
treatment
cetoprostaglandine
compounds
liver disease
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90311457T
Other languages
English (en)
Inventor
Ryuji Ueno
Hiroyoshi Osama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
R Tech Ueno Ltd
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Application granted granted Critical
Publication of ES2085898T3 publication Critical patent/ES2085898T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

UN USO DE UN COMPUESTO DE UNA 15-QUETOPROSTAGLANDINA PARA LA FABRICACION DE UN MEDICAMENTO PARA TRATAMIENTO DE UNA ENFERMEDAD HEPATOBILIAR.
ES90311457T 1989-10-20 1990-10-18 Tratamiento de la enfermedad hepatobiliar con compuestos 15-cetoprostaglandina. Expired - Lifetime ES2085898T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP27460689 1989-10-20

Publications (1)

Publication Number Publication Date
ES2085898T3 true ES2085898T3 (es) 1996-06-16

Family

ID=17544076

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90311457T Expired - Lifetime ES2085898T3 (es) 1989-10-20 1990-10-18 Tratamiento de la enfermedad hepatobiliar con compuestos 15-cetoprostaglandina.

Country Status (10)

Country Link
US (1) US5096927A (es)
EP (1) EP0424156B1 (es)
JP (1) JPH03204816A (es)
KR (1) KR0127297B1 (es)
AT (1) ATE132749T1 (es)
CA (1) CA2027814C (es)
DE (1) DE69024744T2 (es)
DK (1) DK0424156T3 (es)
ES (1) ES2085898T3 (es)
GR (1) GR3018674T3 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE174221T1 (de) * 1990-05-01 1998-12-15 R Tech Ueno Ltd Behandlung von pankreaskrankheit mit 15-keto- prostaglandin e-derivaten
CA2150287C (en) 1994-06-03 2004-08-10 Ryuji Ueno Agent for treating hepato-biliary diseases
JP4091132B2 (ja) * 1997-10-13 2008-05-28 スキャンポ・アーゲー 門脈圧亢進抑制剤
KR100648868B1 (ko) * 1997-11-28 2006-11-24 가부시키가이샤 아루떼꾸 우에노 엔도텔린 길항제
TWI225398B (en) * 1999-07-14 2004-12-21 R Tech Ueno Ltd Composition for treatment of external secretion disorders
NZ521784A (en) * 2000-04-06 2005-04-29 Sucampo Ag Bile secretion promoting composition
TWI302100B (en) * 2001-05-02 2008-10-21 Sucampo Ag Composition for treating drug-induced constipation
AR037524A1 (es) * 2001-11-14 2004-11-17 Sucampo Ag Unidad de dosificacion que comprende un analogo de prostaglandina para el tratamiento de la constipacion
TWI263505B (en) 2001-11-19 2006-10-11 Sucampo Ag Pharmaceutical composition comprising a C1C-2 channel opener
JP2010519177A (ja) * 2007-02-27 2010-06-03 スキャンポ・アーゲー ミトコンドリアを保護するための組成物および方法
US20090082442A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched lubiprostone

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4374856A (en) * 1980-09-10 1983-02-22 The Upjohn Company Liver cytoprotection using PGE's
FR2517679A1 (fr) * 1981-12-03 1983-06-10 Synthelabo Derives de diaza-3,7a cyclohepta (j,k) fluorenes, leur preparation et leur application en therapeutique
JPS58164512A (ja) * 1982-03-25 1983-09-29 Ono Pharmaceut Co Ltd プロスタグランジン類似化合物を有効成分として含有する肝臓疾患治療剤
DE3401542A1 (de) * 1984-01-18 1985-08-01 Merck Patent Gmbh, 6100 Darmstadt Schwefelhaltige 6-ketoprostaglandine
EP0153858A3 (en) * 1984-02-29 1985-12-11 The Upjohn Company The therapeutic use of prostaglandins
JPS62277352A (ja) * 1986-01-30 1987-12-02 Ono Pharmaceut Co Ltd 新規な６−ケト−プロスタグランジンｅ１誘導体、それらの製造方法およびそれらを有効成分として含有する細胞障害治療剤
CA1322749C (en) * 1987-01-28 1993-10-05 Ryuzo Ueno Prostaglandins of the d series, and tranquilizers and soporifics containing the same
CA1323364C (en) * 1987-01-28 1993-10-19 Ryuzo Ueno Prostaglandins e and anti ulcer agents containing same
CA1324129C (en) * 1987-04-30 1993-11-09 Ryuzo Ueno Prostaglandins of the f series
EP0292177B1 (en) * 1987-05-15 1992-03-25 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Fervescence composition
GB2209939B (en) * 1987-09-18 1992-01-02 R Tech Ueno Ltd The use of 13,14-dihydro-15-keto-prostaglandins as ocular hypotensive agents
ES2051862T3 (es) * 1987-10-02 1994-07-01 Ueno Seiyaku Oyo Kenkyujo Kk Un metodo para producir un medicamento que tiene un efecto catartico.
JP2597629B2 (ja) * 1988-02-26 1997-04-09 株式会社 上野製薬応用研究所 １３，１４−ジヒドロ−１５−ケトプロスタグランジン類の安定化
JP2597649B2 (ja) * 1988-05-11 1997-04-09 株式会社上野製薬応用研究所 気管・気管支拡張剤
AU619543B2 (en) * 1988-05-11 1992-01-30 Sucampo Ag Use of 15-ketoprostaglandin e or f compounds for uterine contraction
JPH03101622A (ja) * 1989-09-11 1991-04-26 Green Cross Corp:The 肝炎予防治療剤

Also Published As

Publication number Publication date
EP0424156A3 (en) 1992-04-22
DK0424156T3 (da) 1996-02-05
US5096927A (en) 1992-03-17
CA2027814A1 (en) 1991-04-21
JPH03204816A (ja) 1991-09-06
EP0424156A2 (en) 1991-04-24
KR0127297B1 (ko) 1998-04-01
GR3018674T3 (en) 1996-04-30
DE69024744T2 (de) 1996-05-23
DE69024744D1 (de) 1996-02-22
CA2027814C (en) 1996-07-30
KR910007531A (ko) 1991-05-30
JPH0571568B2 (es) 1993-10-07
EP0424156B1 (en) 1996-01-10
ATE132749T1 (de) 1996-01-15

Similar Documents

Publication Publication Date Title
TW224942B (es)
NO904854D0 (no) 19-nor-vitamin d-forbindelser.
DE3779053D1 (es)
EP0435443A3 (en) Use of 15-keto-prostaglandin compound for improvement of encephalic function
NO890269D0 (no) Fremgangsmaate for fremstilling av 1,4-disubstituerte-piperidinyl-forbindelser.
EP0455448A3 (en) Treatment of pancreatic disease with 15-keto-prostaglandin compounds
ES2093774T3 (es) Estimulacion de la curacion de heridas con un compuesto 15-cetoprostaglandina.
ES2089136T3 (es) Tratamiento de enfermedades inflamatorias con la ayuda de derivados 15-ceto-prostaglandinas.
ES2085898T3 (es) Tratamiento de la enfermedad hepatobiliar con compuestos 15-cetoprostaglandina.
ES2113345T3 (es) Tratamiento de la disfuncion cardiaca con la ayuda de compuestos 15-ceto-prostaglandina.
NO903303L (no) Fremgangsmaate for alfa-hydroksyketoner.
EP0430552A3 (en) Treatment of pulmonary dysfunction with 15-keto-prostaglandin compounds
AU639322B2 (en) Biochemical treatment with 15-dehydroxy-16-oxoprostaglandin compounds
ES2098325T3 (es) Tratamiento de cataratas con compuestos de prostaciclina.
IT1229510B (it) Procedimento per la preparazione di alfa bromoalcilfluoruri.
DE68913972T2 (de) Oxazolidin-Verbindung.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 424156

Country of ref document: ES